Sunday, January 22, 2012

Dana Beal profiled in The New York Times

The New York Times of Jan. 21, 2012, has a very nice profile of Dana Beal in the New York section.

Dana may be best known to the contemporary drug policy reform movement as the irrepressibly persistent promoter of ibogaine for treating addiction. At the conferences of NORML, the Drug Policy Foundation and the Drug Policy Alliance over the past 25 years, he has invariably sought the microphone to inform all present about ibogaine's remarkable therapeutic potential.

At Dana's persistence, one of my first efforts to influence federal policy after I left the House Judiciary Committee staff was to bring Dana and Howard Lotsoff to meet with key officials of the Food and Drug Administration to try to initiate support for ibogaine research and clinical trials.

Dana has been a promoter of legal marijuana for even longer. He and his colleagues have organized countless meetings, conferences, protests and marches, such as the Million Marijuana March.

Sphere: Related Content

1 comment:

FARId said...

Well thanks for your postings, but then you wrote as labels/words, you put a "R" to Ibogaine. and IBOGA